Glycomimetics (GLYC) PT Lowered to $15 at Jefferies; Reiterates Buy
Tweet Send to a Friend
Jefferies lowered its price target on Glycomimetics (NASDAQ: GLYC) to $15.00 (from $16.00) while maintaining a Buy rating following the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
